INJECTION SITE INFLAMMATION

This adverse event was reported 4987 times

These drugs are most commonly taken by patients reporting INJECTION SITE INFLAMMATION:

# Drug Count
0 ETANERCEPT 806
1 DUPILUMAB 492
2 ADALIMUMAB 460
3 METHOTREXATE SODIUM 242
4 METHOTREXATE 234
5 PREDNISONE 170
6 INTERFERON BETA-1A 161
7 TIRZEPATIDE 154
8 GLATIRAMER ACETATE 139
9 ERGOCALCIFEROL 118
See all common drugs associated with INJECTION SITE INFLAMMATION

INJECTION SITE INFLAMMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZOPAPOGENE IMADENOVEC 2 0.0500
1 MOTIXAFORTIDE 2 0.0196
2 COCOA BUTTER, PHENYLEPHRINE HCL 1 0.0196
3 CHLORINE 1 0.0159
4 ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0122
5 ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 7 0.0118
6 RILONACEPT 13 0.0112
7 LENACAPAVIR SODIUM 5 0.0099
8 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 17 0.0090
9 APOMORPHINE HYDROCHLORIDE 15 0.0089
See all drugs enriched for association with INJECTION SITE INFLAMMATION

INJECTION SITE INFLAMMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 15 0.0218
1 Skin Test Antigen [EPC] 17 0.0090
2 Cytolytic Agent [EPC] 17 0.0073
3 Provitamin D2 Compound [EPC] 118 0.0040
4 Melanocortin 4 Receptor Agonist [EPC] 1 0.0035
5 PCSK9 Inhibitor [EPC] 90 0.0035
6 Interleukin-17A Antagonist [EPC] 121 0.0032
7 Leptin Analog [EPC] 4 0.0032
8 Serotonin-4 Receptor Agonist [EPC] 2 0.0030
9 Interleukin-1 Receptor Antagonist [EPC] 51 0.0030
See all drug classes enriched for association with INJECTION SITE INFLAMMATION